Literature DB >> 14680477

A proximal tissue-specific module and a distal negative regulatory module control apolipoprotein(a) gene transcription.

Sarita Negi1, Saurabh K Singh, Nirupma Pati, Vikas Handa, Ruchi Chauhan, Uttam Pati.   

Abstract

The apo(a) [apolipoprotein(a)] gene is responsible for variations in plasma lipoprotein(a), high levels of which are a risk factor for atherosclerosis and myocardial infarction. The apo(a) promoter stimulates the expression of reporter genes in HepG2 cells, but not in HeLa cells. In the present study, we demonstrate that the 1.4 kb apo(a) promoter comprises two composite regulatory regions: a distal negative regulatory module (positions -1432 to -716) and a proximal tissue-specific module (-716 to -616). The distal negative regulatory module contains two strong negative regulatory regions [polymorphic PNR (pentanucleotide repeat region) and NREbeta (negative regulatory element beta)], which sandwich the postive regulatory region PREbeta (positive regulatory element beta). The PNR was shown to bind to transcription factors in a tissue-specific manner, whereas the ubiquitous transcription factors hepatocyte nuclear factor 3alpha and GATA binding protein 4 bound to NREbeta to repress gene transcription. The proximal tissue-specific module contains two regulatory elements: an activating region (PREalpha) that activates transcription in HepG2 cells, and NREalpha, which is responsible for repressing the apo(a) gene in HeLa cells. NREalpha binds to a HeLa-specific repressor. These multiple regulatory elements might work co-operatively to finely regulate apo(a) gene expression. Although the tissue-specific module is required for apo(a) gene activation and repression in a tissue-specific manner, the combinatorial interplay of the distal and proximal regulators might define the complex pathway(s) of apo(a) gene regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14680477      PMCID: PMC1224047          DOI: 10.1042/BJ20030985

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  T cell-specific negative regulation of transcription of the human cytokine IL-4.

Authors:  M Li-Weber; A Eder; H Krafft-Czepa; P H Krammer
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

Review 2.  Lipoprotein (a). Heterogeneity and biological relevance.

Authors:  A M Scanu; G M Fless
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

3.  Preparation of extracts from higher eukaryotes.

Authors:  J D Dignam
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

4.  Two silencers regulate the tissue-specific expression of the collagen II gene.

Authors:  P Savagner; T Miyashita; Y Yamada
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

5.  Identification of a transcriptional silencer in the 5'-flanking region of the human epsilon-globin gene.

Authors:  S X Cao; P D Gutman; H P Dave; A N Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

Review 6.  Lipoprotein(a): an emerging cardiovascular risk factor.

Authors:  Giuseppe Lippi; Giancesare Guidi
Journal:  Crit Rev Clin Lab Sci       Date:  2003-02       Impact factor: 6.250

7.  Positive and negative regulatory elements in the mouse albumin enhancer.

Authors:  R S Herbst; N Friedman; J E Darnell; L E Babiss
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

8.  Characterization of a palindromic enhancer element in the promoters of IL4, IL5, and IL13 cytokine genes.

Authors:  Sandra Codlin; Cecilia Soh; Tak Lee; Paul Lavender
Journal:  J Allergy Clin Immunol       Date:  2003-04       Impact factor: 10.793

9.  Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.

Authors:  E Boerwinkle; C C Leffert; J Lin; C Lackner; G Chiesa; H H Hobbs
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

10.  Negative control of liver-specific gene expression: cloned human retinol-binding protein gene is repressed in HeLa cells.

Authors:  V Colantuoni; A Pirozzi; C Blance; R Cortese
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

View more
  5 in total

Review 1.  Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.

Authors:  Stefan Coassin; Florian Kronenberg
Journal:  Atherosclerosis       Date:  2022-05       Impact factor: 6.847

2.  Functional analysis and identification of cis-regulatory elements of human chromosome 21 gene promoters.

Authors:  Hans-Jörg Warnatz; Robert Querfurth; Anna Guerasimova; Xi Cheng; Stefan A Haas; Andrew L Hufton; Thomas Manke; Dominique Vanhecke; Wilfried Nietfeld; Martin Vingron; Michal Janitz; Hans Lehrach; Marie-Laure Yaspo
Journal:  Nucleic Acids Res       Date:  2010-05-21       Impact factor: 16.971

Review 3.  Lipoprotein(a) metabolism: potential sites for therapeutic targets.

Authors:  Jane Hoover-Plow; Menggui Huang
Journal:  Metabolism       Date:  2012-10-04       Impact factor: 8.694

4.  Investigation of association between PFO complicated by cryptogenic stroke and a common variant of the cardiac transcription factor GATA4.

Authors:  Mahdi Moradi Marjaneh; Edwin P Kirk; Maximilian G Posch; Cemil Ozcelik; Felix Berger; Roland Hetzer; Robyn Otway; Tanya L Butler; Gillian M Blue; Lyn R Griffiths; Diane Fatkin; Jeremy J Martinson; David S Winlaw; Michael P Feneley; Richard P Harvey
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

5.  Diallyl disulphide inhibits apolipoprotein(a) expression in HepG2 cells through the MEK1-ERK1/2-ELK-1 pathway.

Authors:  Xiaofeng Ma; Yami Liu; Yanmei Tan; Kai Qu; Xinglan He; Hai Zhang; Zuo Wang
Journal:  Lipids Health Dis       Date:  2017-11-25       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.